Hypoxia selection of death-resistant cells. A role for Bcl-X(L).
about
Global analysis of DNA methylation by Methyl-Capture sequencing reveals epigenetic control of cisplatin resistance in ovarian cancer cellMinocycline up-regulates Bcl-2 and protects against cell death in mitochondriaRegulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models.The critical role of ERK in death resistance and invasiveness of hypoxia-selected glioblastoma cells.Relationships between hematopoiesis and hepatogenesis in the midtrimester fetal liver characterized by dynamic transcriptomic and proteomic profilesPraf2 is a novel Bcl-xL/Bcl-2 interacting protein with the ability to modulate survival of cancer cellsNutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation.Intermittent hypoxia regulates stem-like characteristics and differentiation of neuroblastoma cells.Effect of culture at low oxygen tension on the expression of heat shock proteins in a panel of melanoma cell lines.Hyperglycemia, p53, and mitochondrial pathway of apoptosis are involved in the susceptibility of diabetic models to ischemic acute kidney injury.Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates.Induction of cellular prion protein (PrPc) under hypoxia inhibits apoptosis caused by TRAIL treatment.Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusins.In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo.Regulation and pathological role of bid in ischemic acute kidney injury.Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours.Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity.Antiangiogenic therapy using endostatin increases the number of ALDH+ lung cancer stem cells by generating intratumor hypoxia.Murine cytomegalovirus infection and apoptosis in organotypic retinal cultures.Knockdown of HIF-1α and IL-8 induced apoptosis of hepatocellular carcinoma triggers apoptosis of vascular endothelial cells.Metabolic Regulation of Apoptosis in Cancer.Hypoxia-induced vasculogenic mimicry formation via VE-cadherin regulation by Bcl-2.BCL-xL is a target gene regulated by hypoxia-inducible factor-1{alpha}.Dihydroartemisinin is a Hypoxia-Active Anti-Cancer Drug in Colorectal Carcinoma Cells.Effects of targeted Bcl-2 expression in mitochondria or endoplasmic reticulum on renal tubular cell apoptosis.Attenuation of oxidative stress in HL-1 cardiomyocytes improves mitochondrial function and stabilizes Hif-1alpha.Array-based comparative gene expression analysis of tumor cells with increased apoptosis resistance after hypoxic selection.Induction of prosurvival molecules by apoptotic stimuli: involvement of FOXO3a and ROS.Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity.Adaptation to survival in germinal center is the initial step in onset of indolent stage of multiple myeloma.Inhibition of apoptosis by Zn2+ in renal tubular cells following ATP depletion.Acidic pH inhibits ATP depletion-induced tubular cell apoptosis by blocking caspase-9 activation in apoptosome.Comparative studies of oxaliplatin-based platinum(iv) complexes in different in vitro and in vivo tumor models.Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53.
P2860
Q28478564-A7CBEC04-8F8F-44D9-85BC-E24C0AEFEA13Q28574259-182193F4-EE59-430A-9321-4EC5461071BFQ30487260-ACD1713C-EF9B-455F-BC7F-D5A56D846F6DQ33401981-AB21685C-C259-42AF-B99F-D175B0A8B93DQ33513479-CA326E0E-A977-4189-B8F0-3BD1B3C707E9Q33784745-2A16CFD4-2381-425A-BCBC-EE5584DC343DQ33808489-8664E808-5DBD-4ED9-97FA-53E14ADAA3CBQ34170335-B8AB0091-6AE3-4B17-9A8E-7944B03C5F52Q34325636-D7E8A577-342F-49CB-AAEF-8F2FE73158C6Q34774010-DEA9154F-1EA0-481F-A844-9C5673C5EF36Q34972161-D1318E5B-D799-4A42-BF2D-E62E85E8117CQ35741681-7CC1A86D-5F1C-41EA-B357-4E7B8E19940DQ35880175-D303AC02-67D2-40C7-9C87-347597391EF1Q36615007-130622DC-0563-44F6-B482-93FA5AA2D93CQ37027420-BE5E5AB2-2A9A-4D38-9334-FFC29FCE8E33Q37150405-46E9B52E-7BE2-42B7-B254-994E18E81033Q37259459-2819AF9C-A282-4BB5-A610-7368F33F89D4Q37310622-FA116C96-B382-49F7-9BA5-F2EFB4F77D6CQ37661144-B0FFDD81-64EA-4757-9027-BADC4C2177EBQ38827855-79A686F6-7CA1-4F01-9334-7FEE653B9E4FQ38969211-3DB2C79D-4474-4A6B-A54E-70C90FCD3D21Q39352857-806BBA45-5B99-414B-A056-C0783F77BD97Q39884888-EBABDB97-DC15-4EAF-9E82-D566C1CB27F3Q39921071-FE71E7D5-DE0B-4C5E-AF2A-77C297607E4BQ40030634-BDF440B1-40DE-4494-9285-B64CC0058464Q40349344-F637D5A0-C660-408C-82D9-E2C18901FF1AQ40421619-B7097F6C-54F6-4A3A-8B2E-A0195AEE649AQ40464860-B1C11F14-CAA3-4B83-BE15-A1A18E526E5CQ40524630-D6C935E9-8D05-487B-84D6-F03AE18BDFF7Q42324181-BC498C3F-82A6-4E87-BFEF-C6D42F782B75Q44869341-FD7D3ED0-692B-4359-AC67-C13A3EE855A2Q46365687-5E4FCD0B-3B43-4E5C-B9E5-C5546FD77CA3Q46417081-0825E7B7-B1CD-47C3-86CD-4CC22D9B1132Q53610659-699F0DAC-81AE-4D28-8468-5B67EFE0773F
P2860
Hypoxia selection of death-resistant cells. A role for Bcl-X(L).
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Hypoxia selection of death-resistant cells. A role for Bcl-X(L).
@en
type
label
Hypoxia selection of death-resistant cells. A role for Bcl-X(L).
@en
prefLabel
Hypoxia selection of death-resistant cells. A role for Bcl-X(L).
@en
P2860
P356
P1476
Hypoxia selection of death-resistant cells. A role for Bcl-X(L).
@en
P2093
Jinzhao Wang
Zheng Dong
P2860
P304
P356
10.1074/JBC.M312225200
P407
P577
2003-12-15T00:00:00Z